Parties Ask 9th Circuit To Unseal Nov. 28 Ruling In Incretin Mimetics MDL Case

(December 4, 2017, 1:56 PM EST) -- SAN FRANCISCO — Defendants and plaintiffs on Dec. 1 and Nov. 30 urged the Ninth Circuit U.S. Court of Appeals to unseal its Nov. 28 order in their appeal of the dismissal of claims involving incretin mimetic diabetes drugs (Jean Adams, et al. v. Merck Sharpe & Dohme Corp., et al., No. 15-56997, 9th Cir.)....